World Small Molecule Kinase Inhibitor Market Is Expected To Reach USD 100.6 Billion by 2027 Growing At A CAGR Of 11.4% From 2020 to 2027: Market.US
The small Molecule Kinase Inhibitor Market is estimated at USD 47.8 Billion in the year 2020 and is projected to reach a revised size of USD 100.6 Billion by 2027, growing at a CAGR of 11.4% over the analysis period 2020-2027. As per the report published by Market.us Titled & Small Molecule Kinase Inhibitor Market by Type [Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa] and By Application [Oncology Diseases, Non-Oncology Diseases]: Global Opportunity Analysis and Industry Forecast, 2022 - 2031” The study analyzes the market in terms of revenue across all the major markets. Different Top key players such as [Bristol-Myers Squibb, Amgen Inc, Wyeth,…
- Date: November 28, 2022
- Author: Quintero
- Category: PharmiWeb